top of page

CRISPR QC Co-founder Kiana Aran Makes Inc.’s 2023 Female Founders List

Read Full Article Here


CRISPR QC is proud to announce that co-founder Kiana Aran has been recognized by Inc. magazine as a top 200 Female Founder. This prestigious list highlights women entrepreneurs who are making a significant impact in their respective industries and driving change.


“As a female founder, I hope to inspire other women to have the courage and intellectual bravery to pursue their entrepreneurial goals”


“As a female founder, I hope to inspire other women to have the courage and intellectual bravery to pursue their entrepreneurial goals,” says Dr. Aran. “The development of CRISPR-Chip technology has proven to be incredibly valuable for the CRISPR industry, and I am thrilled to see the impact of my work. This recognition from Inc. magazine is incredibly rewarding and motivates me to continue pushing boundaries in biotechnology innovations. I am excited to further bridge the gap between the benches in my academic lab and effective commercial applications.”


CRISPR QC congratulates Kiana Aran on this well-deserved recognition and looks forward to her continued leadership.


About CRISPR QC:


CRISPR QC provides innovative solutions for CRISPR research and development. The CRISPR-Chip is the core component of the CRISPR Analytics platform, which uniquely enables real-time, direct measurement of CRISPR activity. Our CRISPR Analytics Platform uses machine learning and data visualization to gain insights into gene editing and accelerate research. We strive to empower our customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by CRISPR editing.


About Inc:


The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning, multiplatform content reaches more than 50 million people each month across a variety of channels, including websites, newsletters, social media, podcasts, and print. For more information, visit www.inc.com.

10 views0 comments

Recent Posts

See All

We are thrilled to share that our CRISPR-Chip, the backbone of our CRISPR Analytics Platform, is now being showcased at the German DHMD museum in Dresden as part of the esteemed exhibition 'Of Genes a

With $1.6 million of seed funding recently added to its balance sheet, CRISPR QC is advancing the commercial development of its data analytics platform for gene editing. READ FULL ARTICLE HERE. The Sa

bottom of page